Dermata Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$3.79 | -$3.79 | -$3.79 |
| Q2 2024 | 1 | -$2.64 | -$2.64 | -$2.64 |
| Q3 2024 | 1 | -$1.36 | -$1.36 | -$1.36 |
Dermata Therapeutics, Inc. Earnings Date And Information
Dermata Therapeutics, Inc. last posted its earnings results on Wednesday, August 7th, 2024. The company reported $-4.18 earnings per share for the quarter, missing analysts' consensus estimates of $-3.79 by $0.39. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Dermata Therapeutics, Inc. has generated $-40 earnings per share over the last year ($-39.98 diluted earnings per share) and currently has a price-to-earnings ratio of -0.16. Dermata Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based on prior year's report dates.
Dermata Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$2.04 | $0 | $0 | ||
| 08/07/2024 | Q2 2024 | -$3.79 | -$4.18 | -0.39 | $0 | $0 |
| 03/30/2024 | Q1 2024 | -$7.06 | $0 | |||
| 03/21/2024 | Q4 2023 | -$0.78 | -$0.54 | 0.24 | $0 | |
| 11/09/2023 | Q3 2023 | -$0.63 | -$0.54 | 0.09 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.92 | -$0.63 | 0.29 | $0 | |
| 05/11/2023 | Q1 2023 | -$2.65 | -$2.23 | 0.42 | $0 | |
| 03/28/2023 | Q4 2022 | -$2.06 | $0 | |||
| 11/10/2022 | Q3 2022 | -$3.52 | -$3.10 | 0.42 | $0 | |
| 08/15/2022 | Q2 2022 | -$5.12 | -$3.90 | 1.22 | $0 | |
| 05/16/2022 | Q1 2022 | -$4.49 | -$5.35 | -0.86 | $0 | |
| 03/28/2022 | Q4 2021 | -$5.68 | -$0.31 | 5.37 | $0 | |
| 11/15/2021 | Q3 2021 | -$7.36 | -$5.50 | 1.86 | $0 | |
| 09/27/2021 | Q2 2021 | -$22.56 | -$2.84 | 19.72 | $0 | |
| 03/30/2021 | Q1 2021 | -$4.43 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.05 | $0 | |||
| 09/29/2020 | Q3 2020 | -$1.15 | $0 | |||
| 06/29/2020 | Q2 2020 | -$1.58 | $0 | |||
| 03/30/2020 | Q1 2020 | -$2.73 | $0 |
Dermata Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Dermata Therapeutics, Inc.'s earnings date?
Dermata Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates.
-
How can I listen to Dermata Therapeutics, Inc.'s earnings conference call?
The conference call for Dermata Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Dermata Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Dermata Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Dermata Therapeutics, Inc. generate each year?
Dermata Therapeutics, Inc. (:DRMA) has a recorded net income of $0. Dermata Therapeutics, Inc. has generated $-40.18 earnings per share over the last four quarters.
-
What is Dermata Therapeutics, Inc.'s price-to-earnings ratio?
Dermata Therapeutics, Inc. (:DRMA) has a price-to-earnings ratio of -0.16 and price/earnings-to-growth ratio is 0.01.
